slight miss, who cares. SNTS heading back up.
Hey Kitty -
I've been out of the country for a while. What have I missed, IF anything??
should also target bowel syndrome drug Gattex NPSP
since SNTS is specialty in GI they could easily enter in any other GI drugs
moneys already been made in npsp
yep, SNTS would be entering in rare disease treatment, look for approval in first quarter of 2014 for HAE where VPHM will get their business wrecked...
The new four investigational drugs would it target some of SLXP business ?
only time will tell
Sentiment: Strong Buy